Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

SHE:002275 Revenue

Guilin Sanjin Pharmaceutical had revenue of 443.48M CNY in the quarter ending June 30, 2026, a decrease of -16.60%. This brings the company's total for the last twelve months to 2.02B, down -5.08% year-over-year. In the year 2025, Guilin Sanjin Pharmaceutical had annual revenue of 2.05B, down -6.76%. That makes Guilin Sanjin Pharmaceutical the 14,491st largest company in the world by revenue and 2,585th in China.

• Revenue (ttm): 2.02B
• Revenue Growth: -5.08%
• P/S Ratio: 3.53
• Revenue / Employee: 788.73K
• Employees: 2,556
• Market Cap: 7.12B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Industry 1.96B 96.0%
• Commodity Circulation (Commercial) 49.90M 2.4%
• Other Business 31.37M 1.5%

By Geography

Chart

• China 2.02B 98.6%
• Overseas 28.87M 1.4%

Fiscal year ended Dec 31, 2025 See the full SHE:002275 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.05B	-148.26M	-6.76%
Dec 31, 2024	2.19B	22.39M	1.03%
Dec 31, 2023	2.17B	211.87M	10.81%
Jan 1, 2023	1.96B	218.51M	12.55%
Jan 1, 2022	1.74B	174.74M	11.15%

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error